Nobumichi Tanaka Selected Research

Nephroureterectomy

1/2021	Hexylaminolevulinate-mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer.
5/2020	Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.
5/2019	Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobumichi Tanaka Research Topics

Disease

82	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 07/2007
62	Neoplasms (Cancer) 05/2024 - 01/2004
26	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 03/2011
24	Carcinoma (Carcinomatosis) 04/2024 - 08/2005
15	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 11/2004
13	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2006
12	Non-Muscle Invasive Bladder Neoplasms 04/2023 - 01/2010
7	Lower Urinary Tract Symptoms 01/2022 - 12/2014
6	Nocturia 05/2023 - 03/2013
6	Adenocarcinoma 12/2020 - 10/2011
5	Polyuria 05/2023 - 06/2011
5	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 12/2009
4	Hemorrhage 03/2024 - 03/2002
4	Inflammation (Inflammations) 11/2023 - 01/2017
4	Margins of Excision 10/2019 - 11/2012
3	Infections 03/2024 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 05/2018
3	Lymphatic Metastasis 09/2022 - 05/2008
3	Urologic Neoplasms (Urological Cancer) 04/2022 - 05/2020
3	Edema (Dropsy) 01/2022 - 06/2011
3	Hypoxia (Hypoxemia) 01/2022 - 03/2011
3	Pain (Aches) 01/2021 - 01/2019
3	Carcinogenesis 12/2020 - 07/2008
3	Thrombosis (Thrombus) 01/2018 - 05/2008
2	COVID-19 03/2024 - 10/2023
2	Disease Progression 08/2023 - 06/2022
2	Sarcopenia 07/2022 - 05/2020
2	Hypertension (High Blood Pressure) 02/2022 - 02/2016
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2019 - 05/2018
2	Small Cell Carcinoma 05/2019 - 04/2007

Drug/Important Bio-Agent (IBA)

13	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 07/2007
11	AndrogensIBA 08/2023 - 06/2010
11	AcidsIBA 10/2022 - 05/2014
9	Iodine-125IBA 08/2023 - 01/2009
7	Gemcitabine FDA Link 03/2023 - 06/2010
7	Small Interfering RNA (siRNA)IBA 05/2020 - 07/2008
6	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
6	Docetaxel (Taxotere)FDA Link 10/2023 - 01/2017
6	Cisplatin (Platino)FDA LinkGeneric 03/2023 - 04/2007
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2009
5	CytokinesIBA 02/2024 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 09/2022 - 05/2014
5	pembrolizumabIBA 09/2022 - 05/2020
5	AntibodiesIBA 06/2019 - 04/2007
4	enfortumab vedotinIBA 04/2024 - 09/2022
4	abirateroneIBA 01/2024 - 10/2017
4	enzalutamideIBA 01/2024 - 10/2017
4	CreatinineIBA 07/2022 - 11/2004
4	protoporphyrin IXIBA 01/2022 - 08/2014
4	Hormones (Hormone)IBA 09/2021 - 11/2012
4	NitrosaminesIBA 06/2021 - 01/2017
4	Sunitinib (Sutent)FDA Link 10/2018 - 06/2012
4	Heme Oxygenase-1IBA 03/2016 - 01/2010
3	CarcinogensIBA 05/2024 - 04/2018
3	PlatinumIBA 04/2024 - 01/2022
3	Prednisolone (Predate)FDA LinkGeneric 03/2024 - 07/2022
3	EnzymesIBA 04/2023 - 01/2018
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020 - 05/2018
3	Syndecan-1 (Syndecan 1)IBA 05/2020 - 12/2013
3	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2019 - 12/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019 - 01/2010
2	HydrogelsIBA 05/2024 - 07/2022
2	NectinsIBA 04/2023 - 09/2022
2	ImmunosorbentsIBA 04/2023 - 01/2018
2	Claudin-4IBA 06/2022 - 11/2020
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 03/2016
2	mirabegronIBA 01/2022 - 04/2017
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2022 - 09/2020
2	naftopidilIBA 11/2021 - 12/2014
2	silodosin FDA Link 11/2021 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 09/2021 - 03/2014
2	5-aminolevulinic acid hexyl ester FDA Link 01/2021 - 11/2017
2	Cadherins (E-Cadherin)IBA 05/2020 - 01/2016
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 04/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2019 - 03/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2019 - 01/2017

Therapy/Procedure

39	Therapeutics 04/2024 - 03/2006
34	Brachytherapy 05/2024 - 01/2009
19	Drug Therapy (Chemotherapy) 04/2024 - 03/2006
19	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 01/2009
17	Radiotherapy 08/2023 - 06/2010
14	Nephrectomy 03/2024 - 08/2005
13	Castration 01/2024 - 04/2014
9	Cystectomy 12/2023 - 01/2016
7	Transurethral Resection of Bladder 03/2023 - 03/2016
5	Kidney Transplantation 10/2023 - 01/2018
3	Immunotherapy 04/2024 - 10/2019
3	Salvage Therapy 08/2023 - 10/2014
3	Nephroureterectomy 01/2021 - 05/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2024 - 01/2018
2	Transplantation 03/2024 - 09/2015
2	Peritoneal Dialysis 11/2023 - 11/2023
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 03/2006
2	Laser Therapy (Surgery, Laser) 04/2022 - 01/2004
2	Oral Administration 06/2021 - 01/2019
2	Operative Time 01/2021 - 02/2019
2	Combination Drug Therapy (Combination Chemotherapy) 07/2020 - 04/2007
2	Neoadjuvant Therapy 10/2019 - 04/2018